How AI is uniting regulatory strategy and biomanufacturing.AI is no longer a futuristic add-on in the life sciences. It is rapidly becoming infrastructure.
News-Medical.Net on MSN
mAbxience selects Genedata Bioprocess to automate end-to-end CDMO workflows
Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess ® enterprise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results